ARS: Annual Report to Security Holders
DEFA14A: Others
DEF 14A: Definitive information statements
PRE 14A: Preliminary proxy statements relating to merger or acquisition
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 424B3: Prospectus
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 8-K: Current report
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 424B5: Prospectus
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | EFFECT: Others
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 10-K: Annual report
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 8-K: eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Bhatt Elizabeth
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Klencke Barbara
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Harrington-Smith Kristen
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Gallagher Brian M. Jr.
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Officer Byrnes Michael
EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Officer Warner Douglas J
No Data